Methods of treatment utilizing canine-specific therapeutic compositions
AssigneeAlphalogix, LLC
InventorsChristian Beaudry, Jaehyun Kim
Life of this patent
Estimating the term…
Abstract
Methods of treating conditions (e.g., cancer) in a subject using a canine-specific therapeutic composition are described herein. The canine-specific therapeutic composition is clear, safe, and physiologically and biologically active. Methods described herein may comprise administering a therapeutic amount of the canine-specific therapeutic composition which may comprise a micronized canine-specific allantoamnion membrane, in a solution. Thus, the present invention features canine-specific therapeutic compositions comprising placental-derived materials and methods of use.
Claims20
A method of treating conditions in a subject, the method comprising administering a therapeutic amount of the canine-specific therapeutic composition comprising a micronized canine-specific allantoamnion membrane, in a solution.
A method of treating cancer in a subject, the method comprising administering a therapeutic amount of the canine-specific therapeutic composition comprising a micronized canine-specific allantoamnion membrane, in a solution to the subject.
A method of treating a target site in a subject, the method comprising administering a therapeutic amount of the canine-specific therapeutic composition comprising a micronized canine-specific allantoamnion membrane, in a solution, to the target site in the subject.
Dependencies are inferred from the claim text.